CA1057295A - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
CA1057295A
CA1057295A CA216,313A CA216313A CA1057295A CA 1057295 A CA1057295 A CA 1057295A CA 216313 A CA216313 A CA 216313A CA 1057295 A CA1057295 A CA 1057295A
Authority
CA
Canada
Prior art keywords
group
compound
formula
symbols
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA216,313A
Other languages
English (en)
French (fr)
Other versions
CA216313S (en
Inventor
Henri Ramuz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA1057295A publication Critical patent/CA1057295A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA216,313A 1973-12-21 1974-12-18 Heterocyclic compounds Expired CA1057295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (1)

Publication Number Publication Date
CA1057295A true CA1057295A (en) 1979-06-26

Family

ID=4429892

Family Applications (4)

Application Number Title Priority Date Filing Date
CA216,313A Expired CA1057295A (en) 1973-12-21 1974-12-18 Heterocyclic compounds
CA324,131A Expired CA1079290A (en) 1973-12-21 1979-03-26 Heterocyclic compounds
CA324,132A Expired CA1072966A (en) 1973-12-21 1979-03-26 Heterocyclic compounds
CA324,130A Expired CA1086320A (en) 1973-12-21 1979-03-26 Heterocyclic compounds

Family Applications After (3)

Application Number Title Priority Date Filing Date
CA324,131A Expired CA1079290A (en) 1973-12-21 1979-03-26 Heterocyclic compounds
CA324,132A Expired CA1072966A (en) 1973-12-21 1979-03-26 Heterocyclic compounds
CA324,130A Expired CA1086320A (en) 1973-12-21 1979-03-26 Heterocyclic compounds

Country Status (24)

Country Link
JP (1) JPS595594B2 (de)
AT (5) AT344693B (de)
AU (1) AU511714B2 (de)
BE (1) BE823625A (de)
CA (4) CA1057295A (de)
CH (3) CH611614A5 (de)
DD (1) DD116829A5 (de)
DE (2) DE2463173C2 (de)
DK (1) DK148323C (de)
ES (5) ES433172A1 (de)
FI (2) FI67216C (de)
FR (1) FR2255064B1 (de)
GB (3) GB1489088A (de)
HK (1) HK43380A (de)
HU (1) HU170429B (de)
IE (1) IE40788B1 (de)
IL (3) IL46146A (de)
LU (1) LU71530A1 (de)
NL (1) NL158496B (de)
NO (1) NO142669C (de)
PH (3) PH19393A (de)
SE (2) SE415763B (de)
YU (1) YU39311B (de)
ZA (1) ZA747526B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (fr) * 1981-10-28 1983-04-29 Delalande Sa Nouveaux derives du benzaldehyde 3-4-diethere et leur procede de preparation
JPS60142297U (ja) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 フオ−クリフトにおける旋回型運転席の回転装置
JPS62171328U (de) * 1986-04-23 1987-10-30
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
CA2471760A1 (en) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Preventives/remedies for urinary disturbance
US20100137403A1 (en) * 2008-07-10 2010-06-03 Scott Malstrom Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
AT349013B (de) 1979-03-12
SE7416086L (de) 1975-06-23
GB1489088A (en) 1977-10-19
DK668174A (de) 1975-08-25
IE40788L (en) 1975-06-21
ES451137A1 (es) 1977-08-16
FR2255064A1 (de) 1975-07-18
DE2463173C2 (de) 1987-01-29
CA1086320A (en) 1980-09-23
AU7600874A (en) 1976-06-03
ZA747526B (en) 1975-12-31
ES451135A1 (es) 1977-08-16
PH19393A (en) 1986-04-07
YU39311B (en) 1984-10-31
YU336874A (en) 1982-05-31
AT344693B (de) 1978-08-10
AT349014B (de) 1979-03-12
FI67216C (fi) 1985-02-11
DE2460593B2 (de) 1979-01-18
ATA38778A (de) 1978-08-15
FI801053A7 (fi) 1981-01-01
IL52844A0 (en) 1977-10-31
DE2460593C3 (de) 1979-09-13
AU511714B2 (en) 1980-09-04
IL46146A0 (en) 1975-03-13
JPS5095267A (de) 1975-07-29
SE415763B (sv) 1980-10-27
LU71530A1 (de) 1976-11-11
HU170429B (de) 1977-06-28
FI352774A7 (de) 1975-06-22
GB1489086A (en) 1977-10-19
ATA38878A (de) 1978-08-15
CA1079290A (en) 1980-06-10
AT349012B (de) 1979-03-12
NO142669B (no) 1980-06-16
PH13396A (en) 1980-03-28
BE823625A (fr) 1975-06-20
DK148323B (da) 1985-06-10
ATA38978A (de) 1978-10-15
PH13326A (en) 1980-03-13
NO744615L (de) 1975-07-21
ATA1022674A (de) 1977-12-15
DK148323C (da) 1986-03-03
NL7416507A (nl) 1975-06-24
CH620920A5 (en) 1980-12-31
ATA39178A (de) 1978-08-15
DD116829A5 (de) 1975-12-12
IL46146A (en) 1980-09-16
NO142669C (no) 1980-09-24
GB1489087A (en) 1977-10-19
SE434746B (sv) 1984-08-13
AU3224278A (en) 1978-05-25
AT350053B (de) 1979-05-10
CH620921A5 (en) 1980-12-31
DE2460593A1 (de) 1975-07-03
ES451134A1 (es) 1977-08-16
IE40788B1 (en) 1979-08-15
CH611614A5 (en) 1979-06-15
FI67216B (fi) 1984-10-31
IL52843A0 (en) 1977-10-31
HK43380A (en) 1980-08-22
ES451136A1 (es) 1977-10-01
ES433172A1 (es) 1977-04-16
JPS595594B2 (ja) 1984-02-06
NL158496B (nl) 1978-11-15
CA1072966A (en) 1980-03-04
FR2255064B1 (de) 1978-03-24

Similar Documents

Publication Publication Date Title
US4705797A (en) N-(3,3-diphenylpropyl) aminoethyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid, compositions and use
CA1147342A (en) Process of producing novel phenylethanolamine derivatives
CA1210770A (en) Leukotriene antagonists
EP0233228A1 (de) Pharmazeutisch wirkzame 2-thiomethyl substituierte 1,4-dihydropyridine
KR880002704B1 (ko) 1,4-디하이드로피리딘 화합물의 제조방법
CA1263959A (en) Process for the preparation of 1-pyridyl-alkyl-4-aryl piperazines which are useful as antihypertensive compounds, their separation into the respective optical antipodes, and the stereoisomeric compounds so obtained
JPH0148272B2 (de)
CA1072966A (en) Heterocyclic compounds
DK170233B1 (da) Fremgangsmåde til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
US4352819A (en) Novel 1-[3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl]-3-phenyl-1-propanones and their salts and a process for the preparation thereof
US4073797A (en) Sulphur containing derivatives
Plati et al. 1, 3, 4-Trisubstituted piperidine derivatives from Mannich bases
EP0281098B1 (de) Benzodioxol-Derivate, diese enthaltende Zusammensetzungen und deren Verwendung zur Herstellung von Medikamenten
US4064271A (en) Emetic tetralones and the use thereof for inducing regurgitation
CA1094073A (en) N-carbonylamino-tetrahydropyridyl derivatives
JPS6135194B2 (de)
US4701534A (en) Azetidine derivative
Barluenga et al. Regiospecific synthesis of isoxazoles by reaction of 1-azabutadiene derivatives with hydroxylamine hydrochloride
CA1312085C (en) Dihydropiridine compounds having unique pharmacological effects, and the process for producing them
US4127588A (en) Sulphur containing derivatives
CA1301753C (en) Process for preparing histamine h_-antagonist and intermediates used in such process
CA1128051A (en) Amino derivatives of 3-alkyl-5-(2-hydroxystyryl)- isoxazoles
SU620209A3 (ru) Способ получени производных арилалкиламина ил их солей
Lednicer et al. Partly reduced biphenyls as central nervous system agents. 1. 4-arylcyclohex-3-enylamines
Batra et al. Chemistry of 5 (2H)‐isoxazolones: Novel conversion of positional isomers